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Abstract- Wharton`s jelly-derived mesenchymal stem cells (WJ-MSCs), have a high proliferation valency 
and they do not produce teratogen or carcinogen after subsequent transplantation. They are known as 
regenerative medicine. Thus more research is needed on the isolation and characterization of mesenchymal 
stem cells. In this experimental study, we obtained Wharton's jelly tissues from mothers during normal 
vaginal delivery, after obtaining their informed consent. Mesenchymal stem cells were isolated from cultured 
Wharton`s jelly, cultured, and were then examined for their proliferation, immunophenotypes, and 
differentiation capacities. The immunophenotypes of WJ-MSCs were analyzed by flow cytometry. 
Differentiation was performed resulting in osteogenic, chondrogenic and adipogenic cells. WJ-MSCs formed 
a homogenous monolayer of adherent spindle-shaped cells. Our results showed the high capacity of the 
proliferation of WJ-MSCs. Immunophenotyping further confirmed the purity of the isolated cells; their 
surface antigen expression showed the phenotypical properties like those of WJ-MSCs. The expanded cells 
were positive for CD 90, CD105, and CD44; they were negative for CD34 and HLA-DR surface markers. 
The cells had the adipocytic, osteocytic and chondrogenic differentiation capacity. The isolation and 
characterization of WJ-MSCs with high purity had been conducted, and the results were obtained in a short 
span. The present study has revealed the feasibility of the culture medium with high glucose and 15% FBS in 
isolation and proliferation of WJ-MSCs. When Wharton`s jelly pieces were put in the dry bottom of the flask, 
very effective separation of the MSCs was achieved.  
© 2018 Tehran University of Medical Sciences. All rights reserved.  
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Introduction 
 
Mesenchymal stem cells (MSCs) are cells with a 
special self-renewal capacity and have the ability to get 
differentiated into ectoderm, endoderm, and mesoderm 
lineages. They also have immune-modulatory and anti-
inflammatory effects (1-3) and are popular known as a 
regenerative medicine (4-6).  
MSCs are identified using three characteristics: (1) 
adherence to the flask bottom, (2) differentiation into 
osteoblasts, chondroblasts and adipocytes and (3) 
expression of specific surface markers of CD90, CD105, 
CD73 and CD44, as well as the lack of expression of 
several markers including CD34 and HLA-DR (4,7,8). 
In the past bone marrow was usually used for 
obtaining mesenchymal stem cells. But now numerous 
articles have been published about using embryonic 
cells, the umbilical cord, umbilical cord blood, and 
Wharton's jelly. MSCs from the umbilical cord or 
Wharton`s Jelly, are easily accessed and obtained 
compared to bone marrow and embryonic stem cells (8).  
Wharton`s jelly-derived MSCs (WJ-MSCs) have a 
high proliferation valency; they do not turn into 
teratogenic or carcinogenic cells in case of 
transplantation (8). The bone marrow and adipose tissue, 
among others, are used as sources of MSCs (9-10), 
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However, bone marrow as a source of MSC, comes with 
several disadvantages. First, only a small portion (0.05-
0.001%) of the body`s bone marrow cells were included 
MSCs (9). Second, bone marrow gathering is the 
invasive and very painful procedure. On the one hand, 
although that adipose tissue is abundant in nature, its 
gathering requires an invasive procedure (10). Besides 
umbilical cord and Wharton`s jelly are better sources for 
MSCs because they are globally accessible tissues and 
their gathering creates no ethical harms since they are 
ordinarily discarded as human waste (11-17). MSC is 
the most important candidate for cellular therapy. This 
matter is well documented by the researches carried out 
in vitro (18), preclinical (19-21), and clinical conditions 
(22-25). 
The aim of this study was to present the relevant 
methods for the isolation and characterization of 
Wharton`s jelly-derived MScs. It also aimed to pay 
special attention to their morphology and the 
differentiation into specific cell types including 
adipocytes, chondrocytes, and osteocytes. Furthermore, 
the immunophenotypes (positive and negative CD 
markers) of the isolated MSCs have been determined.  
  
Materials and Methods 
 
WJ-MSCs culture and expansion 
Wharton`s jelly samples were procured from the 
Obstetrical Department of the Imam Hospital, 
Mazandaran University of Medical Sciences, Sari, Iran. 
The university’s Ethics Committee approved our study 
plan, and the informed consents were obtained from all 
donors. Wharton`s Jelly has been collected from 
healthy full-term women, who underwent an elective 
cesarean section.  
One hour after the collection, the Wharton`s jelly 
was transferred to the laboratory where it was 
disinfected and cut into pieces of 0.5-1𝑚𝑚2.The Pieces 
were transferred to 10𝑐𝑚2 plates, which contained 
High Glucose-Dulbecco`s Modified Eagle Medium-
F12 (HG-DMEM-F12). HG-DMEM-F12 was 
supplemented with 15% FBS (Foetal Bovine Serum), 
Penicillin-100U/ml, Streptomycin-100µg/ml and 
2mMol/L L-glutamine, then it was incubated in a 
humidified atmosphere containing 5%CO2 at 37 ͦ C. 
It should be mentioned that the primary Wharton`s 
jelly was rinsed in phosphate –buffered saline (PBS) to 
eliminate blood clots. The medium was replaced every 
two days. The cells migrated from the explant to 
medium margins. After the cells reached a confluency of 
90% in the second changing medium, the adherent cells 
were harvested with 0.25% trypsin-Ethylene Diamine 
Tetra Acetic acid (EDTA) (Gibco, Germany). Single-
cell suspension was used for subsequent experiments 
and reseeded at a density of 5×105 of cells per 25𝑐𝑚2 in 
culture flask. 
 
Mesodermal lineage differentiation 
The WJ-MSCs were induced to be differentiated into 
adipocytes, osteocytes, and chondrocytes. The 
differentiation protocol has been described previously 
(26). In this way, WJ-MSCs at 1.6 × 105 cells/ml were 
cultured in HG-DMEM-F12 complemented with 15% 
FBS and 2mMol/ L- glutamine and Penicillin-
Streptomycin for 6 days. Then the cells were fixed with 
0.4% paraformaldehyde (PFA) and stained with oil-red-
o (Sigma, USA) to confirm the adipocyte.   
For osteoblastic differentiation, the WJ-MSCs were 
cultured in HG-DMEM-F12 complemented with 10 nM 
b-glycerol phosphate (Sigma U.S.A) and 50mg/ml 
ascorbic acid-2 phosphate (Sigma, U.S.A). After 
fixation, the differentiated cells were stained with 
Alizarin red then the calcium deposition was confirmed. 
For chondrogenesis differentiation, WJ-MSCs were 
seeded in an HG-DMEM-F12 complete culture media at 
1.6×105 cells/ml with 5 μl of chondrogenesis culture 
media for 14 days. The micromass cultures were then 
stained with Alcian blue. 
 
Flow cytometry analysis 
The adherent cells were treated by trypsin-EDTA 
and were collected by centrifugation at 300 g for 5 
minutes. The cells were incubated for ~30 min in 100 µl 
of PBS supplemented with 1% bovine serum albumin 
with the following antibodies: anti-CD44-FITC 
(eBioscience), anti-CD105-PE (eBioscience), anti-
CD34-PerCP (eBioscience), anti-CD90-FITC 
(eBioscience), and anti-HLA-DR-PE (eBioscience). The 
cells were then washed and centrifuged for 5 min at 300 
g. The samples were analyzed by a Partec flow 
cytometer. The percentage of CD44-, CD105-, CD90-, 
CD-34-, and HLA-DR- positive or negative cell 
populations was calculated using the FlowJo FACS 
analysis software.  
 
Results 
 
MSCs morphology 
Spindle-shaped MSCs and fibroblast cells were 
observed clearly under an inverted phase microscope. 
The WJ-MSCs created a homogenous monolayer of 
adherent spindle-shaped cells (Figure 1).  
Mesenchymal stem cells: isolation and characterization 
30    Acta Medica Iranica, Vol. 56, No. 1 (2018)    
The MSCs were cultured and developed to the 
seventh passage. In primary passages, the cells 
proliferated quickly in the form of small spindle-shaped 
fibroblasts. The features of the cells were gradually 
changed as elaborated in the later passages (Figure1). 
 
 
Figure 1. The Wharton`s jelly mesenchymal cells were grown from the edge of tissue explants and homogenous population of fibroblast-like 
MSCs at passage2-3 (× 100) 
 
Multilineage differentiation 
The differentiation capacity of the MSCs towards the 
three lineages (adipogenic, osteogenic, and 
chondrogenic) was confirmed (Figure 2). 
 
 
Figure 2. Multilineage differentiation of WJ-MSCs 
(a) Adipogenesis was detected using oil-red-o staining. (b) Chondrogenesis was detected using Alcian blue. (c) Osteogenesis was detected using 
Alizarin-red staining (×100) 
 
Immunophenotyping of WJ-MSCs 
The immunophenotypes of WJ-MSCs were analyzed 
by flow cytometry. The results showed that WJ-MSCs 
were positive for CD90 (99.30%), CD105 (96.37%), and 
CD44 (83.11%); and were negative for hematopoietic 
marker CD34 (0.72%) and HLA-DR (0.85%) (Figures 3, 
4). 
 
 
 
 
Figure 3. Flow cytometry analysis of mesenchymal stem cells derived from Wharton`s jelly 
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Cell surface markers 
Figure 4. The percentage of WJ-MSCs surface marker expression 
These cells expressed mesenchymal markers (CD90, CD105, CD44) and didn’t express blood markers (CD34, HLA-DR) 
 
In the present study, the MSCs were cultivated with 
HG and 15% FBS, which reached for a confluence of 
90% in the second changing medium. However, in 
contrast, when the MSCs were cultivated with LG and 
10% FBS, the confluence of 90% was obtained in the 
third changing medium. The medium was replaced 
every two days. Thereby, a shortened time span was 
achieved for obtaining WJ-MSCs (Table 1). 
 
Table 1. Comparison of the numbers of changing medium in two different medium to 
reach a confluency of 90%, the medium was replaced every two days 
The number of changing medium Culture Confluency 
II +15%FBS +HG Confluency 90% 
III +10%FBS + LG Confluency 90% 
(HG=High Glucose ; LG=Low Glucose) 
 
Discussion 
 
Since mesenchymal stem cells isolated from Fetal 
tissues are discarded after delivery, and they possess 
similar phenotypes to bone marrow mesenchymal cells, 
so it has been tried to use embryonic tissue an 
alternative to bone marrow (26-27). 
WJ-MSCs are not embryonic stem cells (ESCs) or 
adult stem cells (ASCs). These cells have the properties 
of embryonic stem cells and mature stem cells, which 
provide both embryonic stem cells and adult stem cells 
properties; thus their properties can be a useful source 
for the therapeutic use of stem cells (28). 
In the present study, for the WJ-MSCs, we used flow 
cytometry to determine the positive and negative surface 
CD markers. The results of flow cytometry analysis 
showed that the mesenchymal stem cells derived from 
Wharton`s jelly were positive for CD90 (99.30%), 
CD105 (96.37%), and CD44 (83.11%); while they were 
negative for hematopoietic CD34 (0.72%) and HLA-DR 
(0.85%). 
For the growth of WJ-MSCs, Chenphop et al., 
(2014) applied 10% FBS and Low Glucose (29); Nekoei 
et al., (2015) applied 10% FBS and HG- DMEM (30); 
Fong et al., (2007) used HG-DMEM medium 
supplemented with 15% FBS (8).  
In this study, more high-quality the MSCs with 
desired purity and adequate flow cytometry results were 
obtained by following several techniques and methods 
that were employed. Complying with the cooling chain 
requirements is important in terms of sample transfer. 
On the other hand, use of smaller Wharton's jelly caused 
the easier separation of MSCs. The important point is 
that in the first step for separating, millimeter-sized 
Wharton's jelly placed a dry flask bottom followed by, 
the addition of culture medium. If we place a piece of 
the Wharton's jelly into the flask containing the medium, 
it will not get strongly attached to the bottom of flask, 
and hence cell separation does not take place easily. In 
our study, HG-DMEM -F12 +15% FBS+L-
glutamin+Penicillin/Streptomycin was used instead of 
Low Glucose DMEM-F12 and 10% FBS. Finally, we 
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obtained more appropriate mesenchymal stem cells 
within a shorter time.  
We suggest further works to obtain a quick access to 
the WJ-MSCs with high purity percentages in a culture 
medium using different qualitative and quantitative 
methods. 
In this study, the isolation and characterization of 
WJ-MSCs was achieved with high purity and obtained 
at a more suitable time. This research showed that the 
culture with high glucose and 15%FBS with putting 
pieces of Wharton`s Jelly to the dried bottom flask 
achieved a very effective separation of the MSCs. 
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